SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001757064-24-000015
Filing Date
2024-09-19
Accepted
2024-09-19 16:12:12
Documents
7
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K gnft-6xkfrontpageword2024.htm 6-K 27412
2 EX-99.1 HALF YEAR 2024 REPORT a2024-rfs6kxgenfit.htm EX-99.1 1666220
3 a0logogenfitwhiteprotectio.jpg GRAPHIC 64716
4 image_2.jpg GRAPHIC 25156
5 logo.jpg GRAPHIC 131501
6 pipelineen.jpg GRAPHIC 1125045
7 visuel3franchisesen.jpg GRAPHIC 1081603
  Complete submission text file 0001757064-24-000015.txt   5031244
Mailing Address PARC EURASANTE 885, AVENUE EUGENE AVINEE LOOS I0 59120
Business Address PARC EURASANTE 885, AVENUE EUGENE AVINEE LOOS I0 59120 33 3 20 16 4000
Genfit S.A. (Filer) CIK: 0001757064 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38844 | Film No.: 241310545
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)